GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

Size: px
Start display at page:

Download "GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)"

Transcription

1 When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on available from web site) Remember: - Oral feeding is simpler and safer than artificial methods - Give small amounts frequently (3-4 hourly) - Intake should be limited at first and increased slowly - Weekly weight gain of kg generally regarded as optimum Step 1. Decide whether patient is at high or normal risk of re-feeding: The patient is at high risk if they have One or more of the following: - BMI less than 16 kg/m2 - Unintentional weight loss greater than 15% within the last 3 6 months - little or no nutritional intake for more than 10 days - low levels of potassium, phosphate or magnesium prior to feeding. Two or more of the following: - BMI less than 18.5 kg/m2 - Unintentional weight loss greater than 10% within the last 3 6 months - little or no nutritional intake for more than 5 days - a history of alcohol abuse or drugs including insulin, chemotherapy, antacids or diuretics. Step 2. Decide rate of re-feeding: - If normal risk, start nutrition support at a maximum of 10 kcal/kg/day, increasing levels slowly to meet or exceed full needs by 4 7 days (see sample meal plans) If normal risk: number of kcals to be given / day: Weight Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 on Adm. 30 kg kg kg kg kg kg kg

2 - If high risk, commence feeding at only 5 kcal/kg/day in extreme cases (see sample meal plans) - Restore circulatory volume and monitoring fluid balance and overall clinical status closely If High risk: number of kcals to be given / day: Weight Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 on Adm. 30 kg kg kg kg kg kg kg Step 3. Before and during the first 10 days of feeding: - Oral thiamin mg daily, - Vitamin B co strong 1 or 2 tablets, three times a day (or full dose daily intravenous vitamin B preparation, if necessary) (i.e one pair of Pabrinex IV high potency ampoules. Ensure facilities for treating anaphylylaxis are available during administration). - A balanced multivitamin/trace element supplement once daily e.g. Forceval 1 x capsule daily - Provide oral, enteral or intravenous supplements of potassium (likely requirement 2 4 mmol/kg/day), phosphate (likely requirement mmol/kg/day) and magnesium (likely requirement 0.2 mmol/kg/day intravenous, 0.4 mmol/kg/day oral) unless pre-feeding plasma levels are high. - Pre-feeding correction of low plasma levels is unnecessary. Step 4. Correction of Electrolyte Disturbances: (see over) - Biochemical monitoring should guide need for replacement - Electrolytes may change rapidly during first week - Can be replaced orally or intravenously (if absolutely necessary and with caution) - Electrolytes are closely inter-related - Hypo-magnesaemia may cause hypo-kalaemia - Replacement of phosphate may cause calcium to drop Detailed guidance on electrolyte replacement in: Guidelines for the nutritional management of anorexia nervosa (Royal College of Psychiatrists, 2005)

3 Micronutrient Supplements: - Micronutrient supplement recommended in both in-patients and outpatients - Forceval or Sanatogen Gold (non-nhs) - Compound preparations may not contain enough thiamin to meet metabolic demands of re-feeding - Oral thiamin (25-50 mg/day) recommended for in-patients and outpatients undergoing rapid weight gain Suggested replacement therapy in a depleted patient: Phosphate Correction If <0.30mmol/l and renal function/ calcium levels are normal, correct using Phosphate Polyfusor (contains 50mmol phosphate in 500mls). Maximum rate of 9mmol of phosphate over 12hrs (faster rates may be given in ITU), therefore 90ml of Phosphate Polyfusor in 12hrs, administer at 7.5ml/hour (total of 180mls). Re-check phosphate levels daily and repeat above infusion if levels remain <0.30mmol/l. If levels are between 0.30mmol/l - 0.5mmol/l, administer 3 tablets daily (maximum) of Phosphate-Sandoz via the enteral route. Potassium Correction If < 3mmol/l, correct using 1litre of saline and 40mmol of K per litre, over a minimum of 2 hours If levels are between 3-3.5mmol/l, administer Sando K, one tablet three times a day. Magnesium Correction If <0.5mmol/l, correct using 10ml of Magnesium Sulphate 50% (contains 20mmol magnesium) in 100ml of suitable fluid (e.g. sodium chloride 0.9%) over a minimum of 2½ hours. Oral preparations are generally not recommended due to tolerance and side effects of large doses. Average deficit in symptomatic magnesium deficiency is 1mmol/kg (can replace up to 50mmol a day). Monitor levels and repeat once daily until levels >0.5mmol/l.

4 Step 5. Feed as per meal plan. - Contact Dietitian if there are any problems, questions or if you would like any further information re: the above Step 6. Dietitian will aim to review patient in person as soon as possible

5

6 Time Frame for Re-feeding Treat or prevent: Hypoglycaemia Hypothermia Dehydration Correct electrolyte imbalance Days 1-2 Days 3-7 Weeks 2-6 Weeks 7 Correct micronutrient deficiencies Begin feeding Increase feeding to recover lost weight without iron with iron

Refeeding syndrome a practical approach

Refeeding syndrome a practical approach Refeeding syndrome a practical approach PENG pre-bapen Conference Teaching Day Birmingham Monday 20 th November 2017 Rhys White Acting Clinical and Operational Lead Dietitian Guys and St Thomas NHS Foundation

More information

Acute management of severe malnutrition. Dr Simon Gabe St Mark s Hospital, London

Acute management of severe malnutrition. Dr Simon Gabe St Mark s Hospital, London Acute management of severe malnutrition Dr Simon Gabe St Mark s Hospital, London Malnutrition definition A state resulting from lack of uptake or intake of nutrition leading to altered body composition

More information

Prevention of Electrolyte Disorders Refeeding Syndrome พญ.น นทพร เต มพรเล ศ

Prevention of Electrolyte Disorders Refeeding Syndrome พญ.น นทพร เต มพรเล ศ Prevention of Electrolyte Disorders Refeeding Syndrome พญ.น นทพร เต มพรเล ศ Outline Refeeding Syndrome What is refeeding syndrome? What Electrolytes and minerals are involved? Who is at risk? How to manage

More information

Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines Formulary and Prescribing Guidelines SECTION 15: TREATMENT OF EATING DISORDERS 15.1 Introduction Please review the Trust document Guidelines for the assessment and treatment of eating disorders in the

More information

Refeeding Syndrome Guideline

Refeeding Syndrome Guideline Refeeding Syndrome Guideline Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance Committee Pamela Miller Biochemistry Implementation Date: January 2017 Version Number:

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults

NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults NHS Grampian Staff Guideline For The Management Of Acute Hypophosphataemia In Adults Co-ordinators: Medicine Information Pharmacist Consultation Group: See Page 5 Approver: Medicine Guidelines and Policies

More information

MANAGEMENT AND PREVENTION OF REFEEDING SYNDROME IN INPATIENTS: A PRACTICAL APPROACH

MANAGEMENT AND PREVENTION OF REFEEDING SYNDROME IN INPATIENTS: A PRACTICAL APPROACH MANAGEMENT AND PREVENTION OF REFEEDING SYNDROME IN INPATIENTS: A PRACTICAL APPROACH Prof. Zeno Stanga, MD Nutritional Medicine Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism

More information

Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome)

Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome) Out of Hours Emergency Enteral Feeding Regimen (Including Risk Reduction for Re-feeding Syndrome) This guidance does not override the individual responsibility of health professionals to make appropriate

More information

Does the patient need an enteral feed out of hours?

Does the patient need an enteral feed out of hours? Out of hours Enteral tube feeding (Nasogastric) Starter Regimen for an Adult Inpatient With Renal Failure (Including management of re-feeding syndrome) Guidance for Practice 1. Introduction 1.1 This clinical

More information

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia

More information

TOTAL PARENTERAL NUTRITION

TOTAL PARENTERAL NUTRITION TOTAL PARENTERAL NUTRITION Indication See algorithm. Timing Start TPN as indicated on algorithm 1. There is no need to build up TPN volume. The volume of TPN (including lipids) should equate to the total

More information

Title The Prescription of Adult Inpatient Parenteral Nutrition (PN) Guideline. Author s job title Consultant Gastroenterologist Directorate Medicine

Title The Prescription of Adult Inpatient Parenteral Nutrition (PN) Guideline. Author s job title Consultant Gastroenterologist Directorate Medicine Document Control Title The Prescription of Adult Inpatient Parenteral Nutrition (PN) Guideline Author Author s job title Consultant Gastroenterologist Directorate Medicine Department Medicine Version Date

More information

BNF 9: Blood and Nutrition

BNF 9: Blood and Nutrition FORMULARY CHOICE RESTRICTED 1 Blood and Blood-Forming Organs 1.1 Anaemias Epoetins Epoetinalfa pre-filled (Eprex ) 1,000unit 2,000unit 3,000unit 4,000unit 5,000unit 6,000unit 8,000unit 10,000unit 20,000unit

More information

Dutch consensus statement on Refeeding syndrome

Dutch consensus statement on Refeeding syndrome Dutch consensus statement on Refeeding syndrome Introduction Disease related malnutrition is a common problem in health care. The refeeding syndrome is defined as the severe and potentially fatal shifts

More information

Glutaric aciduria type 1 (GA1) Dietetic Management Pathway

Glutaric aciduria type 1 (GA1) Dietetic Management Pathway Glutaric aciduria type 1 (GA1) Dietetic Management Pathway Presumptive positive screen for GA1 See Clinical Management Guidelines and Clinical Referral Guidelines and Standards (www.bimdg.org) Unwell baby:

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine

More information

GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE

GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE GESTATIONAL DIABETES (DIET/INSULIN/ METFORMIN) CARE OF WOMEN IN BIRTHING SUITE DEFINITION A disorder characterised by hyperglycaemia first recognised during pregnancy due to increased insulin resistance

More information

Refeeding Low Weight Adolescents with AN

Refeeding Low Weight Adolescents with AN RCPsych ED 2013 Refeeding Low Weight Adolescents with AN Graeme O Connor RD PhD Research Student -UCL Specialist paediatric Dietitian Great Ormond Street Hospital Foundation Trust Pathophysiology of starvation

More information

NUTRITION. Elizabeth Viner Smith & Catherine Jones Foundations of Critical Care Nursing September 2017

NUTRITION. Elizabeth Viner Smith & Catherine Jones Foundations of Critical Care Nursing September 2017 NUTRITION Elizabeth Viner Smith & Catherine Jones Foundations of Critical Care Nursing September 2017 Step One Competency 1.19 Factors contributing to nutritional impairment in critical illness. Nutritional

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

Guidelines for managing adults at risk of refeeding syndrome.

Guidelines for managing adults at risk of refeeding syndrome. Guidelines for managing adults at risk of refeeding syndrome. Version: V3.0 Ratified by: Out of Hospital Division Governance Meeting Clinical Nutrition Group Date ratified: 12 th January 2018 Name of author

More information

A Guide to Prescribing Adult Oral Nutritional Supplements in West Kent CCG

A Guide to Prescribing Adult Oral Nutritional Supplements in West Kent CCG A Guide to Prescribing Adult Oral Nutritional Supplements in West Kent CCG Aim This guideline has been designed to support primary care prescribers initiating nutrition support for adults in West Kent.

More information

Nutritional management of eating disorders. Louise Watson Clinical Dietitian South Island Eating Disorders Service

Nutritional management of eating disorders. Louise Watson Clinical Dietitian South Island Eating Disorders Service Nutritional management of eating disorders Louise Watson Clinical Dietitian South Island Eating Disorders Service Contents Refeeding syndrome Target weight range Measuring height and weight Refeeding syndrome

More information

Nutrition in Pancreatic Cancer. Edmond Sung Consultant Gastroenterologist Lead Clinician for Clinical Nutrition and Endoscopy

Nutrition in Pancreatic Cancer. Edmond Sung Consultant Gastroenterologist Lead Clinician for Clinical Nutrition and Endoscopy Nutrition in Pancreatic Cancer Edmond Sung Consultant Gastroenterologist Lead Clinician for Clinical Nutrition and Endoscopy Overview The pancreas and nutrition Nutrition screening - can we do this well?

More information

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist

Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist CLINICAL GUIDELINES ID TAG Title: Author: Designation: Speciality / Division: Directorate: Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick

More information

Intensive Care Nutrition. Dr Alan Race BSc(Hons) PhD FRCA

Intensive Care Nutrition. Dr Alan Race BSc(Hons) PhD FRCA Intensive Care Nutrition Dr Alan Race BSc(Hons) PhD FRCA Objectives 1. What examiners say 2. Definition 3. Assessment 4. Requirements 5. Types of delivery 6. CALORIES Trial 7. Timing 8. Immunomodulation

More information

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Medicines Formulary Nutrition, blood and electrolyte disorders Contents: Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3 Blood disorders 3 4. Anaemia 3 A.

More information

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies Contents: Blood disorders 1 1. Anaemia 2 A. Non-renal patients 2 B. Patients with chronic kidney disease under the care of

More information

Bangladesh Breastfeeding Foundation

Bangladesh Breastfeeding Foundation Dealing with Child Undernutrition Using Local Foods: Experience from Bangladesh WBC 2012 New Delhi Dr. S. K. Roy MBBS, MSc. Nutri., Dip-in-Biotech, PhD, FRCP, Chairperson, Bangladesh Breastfeeding Foundation

More information

INTRAVENOUS FLUID THERAPY

INTRAVENOUS FLUID THERAPY INTRAVENOUS FLUID THERAPY PRINCIPLES Postnatal physiological weight loss is approximately 5 10% in first week of life Preterm neonates have more total body water and may lose 10 15% of their weight in

More information

Weekly Cisplatin + Radiotherapy - Interlace study -

Weekly Cisplatin + Radiotherapy - Interlace study - Weekly Cisplatin + Radiotherapy - Interlace study - A phase III multicentre trial of weekly induction chemotherapy followed by standard chemoradiation versus standard chemoradiation alone in patients with

More information

PARENTERAL NUTRITION

PARENTERAL NUTRITION PARENTERAL NUTRITION DEFINITION Parenteral nutrition [(PN) or total parenteral nutrition (TPN)] is the intravenous infusion of some or all nutrients for tissue maintenance, metabolic requirements and growth

More information

Basic Fluid and Electrolytes

Basic Fluid and Electrolytes Basic Fluid and Electrolytes Chapter 22 Basic Fluid and Electrolytes Introduction Infants and young children have a greater need for water and are more vulnerable to alterations in fluid and electrolyte

More information

ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION

ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION Management of the severely malnourished: the case of anorexia nervosa C. De la Cuerda (ES) Management of the severely

More information

Policy Compliance Procedure

Policy Compliance Procedure Policy Compliance Procedure Safe Handling of Adult Intravenous Potassium Chloride Preparations This PCP relates to NSW Health PD NSW Health Policy Directive PD2005_342 Safe Handling of Intravenous Potassium

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.

More information

Over-feeding and over- hydration in elderly medical patients Lessons from the Liverpool Care Pathway. Correspondence to: Abstract Keywords

Over-feeding and over- hydration in elderly medical patients Lessons from the Liverpool Care Pathway. Correspondence to: Abstract Keywords Over-feeding and over-hydration in elderly medical patients Lessons from the Liverpool Care Pathway. Eleni Tsiompanou; Caroline Lucas; Lulu Kreeger; Mike Stroud Correspondence to: Dr Eleni Tsiompanou,

More information

Gemcitabine + Cisplatin Regimen

Gemcitabine + Cisplatin Regimen Gemcitabine + Cisplatin Regimen Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Indication

More information

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines

More information

Tumour Lysis Syndrome (TLS)

Tumour Lysis Syndrome (TLS) (TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This

More information

6-7 JULY 2015, BIRMINGHAM CONGRESS

6-7 JULY 2015, BIRMINGHAM CONGRESS 6-7 JULY 2015, BIRMINGHAM CONGRESS Keywords: /Malnutrition/ Enteral feeding/critical illness This article has been double-blind peer reviewed Patients who are critically ill are at greater risk of malnutrition

More information

Insulin Tolerance Test Protocol - RNS Endocrinology

Insulin Tolerance Test Protocol - RNS Endocrinology Page 1 of 7 - RNS Endocrinology Test name Insulin tolerance test. Alternate test names. Related Tests. Indication(s) Investigation of the hypothalamic pituitary axis (HPA) with regard to the release of

More information

Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter

Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter for nutrients and wastes Lubricant Insulator and shock

More information

INTRAVENOUS FLUIDS PRINCIPLES

INTRAVENOUS FLUIDS PRINCIPLES INTRAVENOUS FLUIDS PRINCIPLES Postnatal physiological weight loss is approximately 5-10% Postnatal diuresis is delayed in Respiratory Distress Syndrome (RDS) Preterm babies have limited capacity to excrete

More information

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/

More information

Electrolyte Disorders in ICU. Debashis Dhar

Electrolyte Disorders in ICU. Debashis Dhar Electrolyte Disorders in ICU Debashis Dhar INTRODUCTION Monovalent ions most important Na,K main cations and Cl &HCO - 3 main anions Mg,Ca & Phosphate are major divalent ions Normal Physiology Body tries

More information

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart

September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart September 14 V0.17 Aims and outcomes of session. Aim: To provide guidance on correctly completing the paediatric daily fluid prescription & balance chart. Outcomes: Demonstrate the ability to: calculate

More information

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient KLORUR NATRIUMI Solution for injection 1000 mg / 10 ml (10 %) Solution for injection 85 mg / 10 ml (0.85 %) Solution for infusion 0.9% (Sodium chloride) Read

More information

NUTRITIONAL REQUIREMENTS

NUTRITIONAL REQUIREMENTS NUTRITION AIMS To achieve growth and nutrient accretion similar to intrauterine rates To achieve best possible neurodevelopmental outcome To prevent specific nutritional deficiencies Target population

More information

PATIENTS PRESENTING WITH SUSPECTED OR CONFIRMED ANOREXIA NERVOSA

PATIENTS PRESENTING WITH SUSPECTED OR CONFIRMED ANOREXIA NERVOSA Guideline for Treating Patients with Anorexia Nervosa when Admitted as a Medical Emergency Trust Reference E2/2012 PATIENTS PRESENTING WITH SUSPECTED OR CONFIRMED ANOREXIA NERVOSA AN CONFIRMED Inform Gastro

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021 NHS...... Grampian NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Consultation Group: Approver:. Senior Medicines Information Pharmacist See Page 4 Medicine

More information

ECX. Anti-emetics: Day 1: highly emetogenic Days 2 21: mildly emetogenic

ECX. Anti-emetics: Day 1: highly emetogenic Days 2 21: mildly emetogenic Page 1 of 5 As an alternative to ECF: For locally advanced (inoperable) or metastatic oesophageal or gastric cancer; peri-operative use in oesophageal or gastric cancer; adenocarcinoma of unknown primary

More information

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy

Magnesium Sulphate - Management of Hypertensive Disorders of Pregnancy 1. Purpose Magnesium sulphate is the anticonvulsant of choice for pre-eclampsia prophylaxis and treatment. This clinical guideline outlines the indications, contraindications, administration and monitoring

More information

Paediatric Best Practice Guidelines. Eating Disorders

Paediatric Best Practice Guidelines. Eating Disorders Paediatric Best Practice Guidelines Eating Disorders Background Relatively common 0.5-0.7% adolescent females have anorexia nervosa, 5-10% of eating disorders occur in males. Anorexia nervosa associated

More information

Guidelines for the Prevention and Management of Hypoglycaemia

Guidelines for the Prevention and Management of Hypoglycaemia ASHFORD & ST PETER S HOSPITALS NHS TRUST CHILDREN S SERVICES Guidelines for the Prevention and Management of Hypoglycaemia 1. The Care Plan for Prevention of Hypoglycaemia on Labour Ward and the Postnatal

More information

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE

TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE TYPE 1 DIABETES MELLITIS CARE OF WOMEN IN BIRTHING SUITE DEFINITION Type 1 Diabetes: described as a total lack of insulin produced by the pancreas for the requirements of the tissues. If left untreated,

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS

More information

Inflammatory Bowel Disease

Inflammatory Bowel Disease + Inflammatory Bowel Disease Christina Kalafsky, Dietetic Intern University of Maryland College Park Children s National Medical Center Case Study January 31, 2014 + Outline n Inflammatory Bowel Disease

More information

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Diabetes Emergency Caesarean section or other unplanned surgery (GL822) Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.

More information

Pediatric Dehydration and Oral Rehydration. May 16/17

Pediatric Dehydration and Oral Rehydration. May 16/17 Pediatric Dehydration and Oral Rehydration May 16/17 Volume Depletion (hypovolemia): refers to any condition in which the effective circulating volume is reduced. It can be produced by salt and water loss

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Intravenous fluid therapy in adults in hospital Quality standard title: Intravenous fluid

More information

Fluid therapy in children

Fluid therapy in children Fluid therapy in children TJ Neuhaus and G Reusz Lucerne and Budapest ESPN 2012 Kraków Parenteral maintenance in children Daily requirements - Holliday and Segar, 1957 Fluid Patient weight: 25 kg 1-10

More information

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY

MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY MANAGEMENT OF PREGNANT WOMEN WITH DIABETES WHO ARE IN-PATIENTS IN THE ROYAL INFIRMARY Background Management is different in different groups of women with diabetes. Women with Type 1 Diabetes (previously

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully. It provides a summary of information about your medicine.

More information

Case Study: Nutritional management of a patient at high risk of developing refeeding syndrome

Case Study: Nutritional management of a patient at high risk of developing refeeding syndrome Case Study: Nutritional management of a patient at high risk of developing refeeding syndrome Dolman RC, PhD, Senior Lecturer; Conradie C, MSc, Lecturer Lombard MJ, PhD, Senior Lecturer; Nienaber A, MSc,

More information

5-FU & Cisplatin + Cetuximab

5-FU & Cisplatin + Cetuximab 5-FU & Cisplatin + Cetuximab Available for Routine Use in Not routinely commissioned, each case requires prior documented approval before offering & commencing therapy from either: a) the relevant PCT

More information

Electrolytes Solution

Electrolytes Solution Electrolytes Solution Substances that are not dissociated in solution are called nonelectrolytes, and those with varying degrees of dissociation are called electrolytes. Urea and dextrose are examples

More information

SECTION 15: TREATMENT OF EATING DISORDERS. Formulary and Prescribing Guidelines

SECTION 15: TREATMENT OF EATING DISORDERS. Formulary and Prescribing Guidelines SECTION 15: TREATMENT OF EATING DISORDERS Formulary and Prescribing Guidelines 15.1 Introduction Please review the Trust document Guidelines for the assessment and treatment of eating disorders in the

More information

Cisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer

Cisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer Cisplatin / Capecitabine (+ Trastuzumab) in Gastric Cancer Page 1 of 5 Indication: Confirmed HER2-positive (3+ or FISH+) metastatic adenocarcinoma of the stomach or gastrooesophageal junction. Patient

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT *****ALSO ORDER SUB ACUTE DKA IV FLUIDS REGIMEN & SUB ACUTE ELECTROLYTE REPLACEMENT on separate forms ***** Condition/Status For purpose of this DKA Regimen, DKA is considered clear

More information

Dr Roger Morgan. Psychiatrist Princess Margaret Hospital Christchurch

Dr Roger Morgan. Psychiatrist Princess Margaret Hospital Christchurch Dr Roger Morgan Psychiatrist Princess Margaret Hospital Christchurch What are we dealing with? Eating disorders are the 3 rd most common disease of young women High mortality High morbidity High co morbidity

More information

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline 1.1. This guideline contains recommendations about general principles for managing intravenous (IV)

More information

Chapter 9 Nutrition and Blood

Chapter 9 Nutrition and Blood Chapter 9 page number 1 Chapter 9 Nutrition and Blood First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary

More information

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.

Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs. NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: 56689 Direct Line: 01224 556689

More information

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission. Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:

More information

Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy

Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy 1 REGIMEN TITLE: Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy Page 1 of 5 Indication: First line in Radical/ Induction, Adjuvant and Advanced & Palliative treatment of Non-small cell lung cancer

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in

More information

STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS

STANDARD FORMULATED SUPPLEMENTARY SPORTS FOODS STANDARD 2.9.4 FORMULATED SUPPLEMENTARY SPORTS FOODS Purpose This Standard defines and regulates the composition and labelling of foods specially formulated to assist sports people in achieving specific

More information

Gemcitabine & Cisplatin

Gemcitabine & Cisplatin Gemcitabine & Cisplatin Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Indication Advanced

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 3 Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients Sodium Chloride Glucose Anhydrous

More information

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults

NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Sarah Gethings Medicine Information Pharmacist Consultation Group: See Page 4 Approver: Medicine Guidelines and

More information

Refeeding syndrome: An overlooked condition?

Refeeding syndrome: An overlooked condition? Focused Review Refeeding syndrome: An overlooked condition? Yuttiwat Vorakunthada MD, Passisd Laoveeravat MD, Wasawat Vutthikraivit MD, Weerapong Lilitwat MD, FAAP, Ariwan Rakvit MD, FACG Abstract Refeeding

More information

Nutritional support on the Acute Medical Unit. Acute Medicine Conference 2017

Nutritional support on the Acute Medical Unit. Acute Medicine Conference 2017 Nutritional support on the Acute Medical Unit Acute Medicine Conference 2017 Declaration of interests Travel grants to attend scientific/educational meetings: Shire Boston Scientific Almirall Organisational

More information

PHARMACOLOGY AND PHARMACOKINETICS

PHARMACOLOGY AND PHARMACOKINETICS DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician

More information

Long term monitoring. Dr Alison Culkin Research Dietitian St Mark s Hospital

Long term monitoring. Dr Alison Culkin Research Dietitian St Mark s Hospital Long term monitoring Dr Alison Culkin Research Dietitian St Mark s Hospital Patient 23 year old lady 1/4/14 Colectomy for UC 3-7/4/14 Ischaemic bowel 4 laparotomies Jejunostomy at 35 cm 23/5/14 Weight

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex peri Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully before you start using this medicine because it contains

More information

Bevacizumab + Paclitaxel + Cisplatin

Bevacizumab + Paclitaxel + Cisplatin Bevacizumab + Paclitaxel + Cisplatin Available for Routine Use in Not routinely commissioned, each case requires prior documented approval before offering & commencing therapy from the Cancer Drugs Fund

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 October 2011 PEDIAVEN AP-HP G15, solution for infusion 1000 ml of solution in two chamber bag, B/4 (CIP code: 419

More information

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259 Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor:

More information

Supplementary Table 1. Patient demographics and baseline characteristics (treated patients).

Supplementary Table 1. Patient demographics and baseline characteristics (treated patients). Supplementary Table 1. Patient demographics and baseline characteristics (treated patients). Placebo (n=188) 10 mg (n=186) 25 mg (n=189) Total (n=563) Gender, n (%) Male 75 (40) 97 (52) 84 (44) 256 (45)

More information

Diabetes Labour guideline (GL820)

Diabetes Labour guideline (GL820) Diabetes Labour guideline (GL820) Approval Approval Group Job Title, Chair of Committee Date Maternity & Childrens Services Mr Mark Selinger, Consultant 6 th June 2014 Clinical Governance Committee Obstetrician

More information

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION!

HHS. Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours. Page 1 of 2 AFFIX PATIENT LABEL ! INFORM DIABETES TEAM OF ADMISSION! Hyperglycaemic Hyperosmolar State Care Pathway 1 Presenta8on to 6 hours Page 1 of 2 Time of Arrival Loca8on Date / / Diagnosis the characteris8c features of a person with HHS are a) Hypovolaemia b) Marked

More information

Targeted Employees/ Departments: Clinical Nutrition Department, Food Services Department, Catering Services, Nursing Department and Physicians

Targeted Employees/ Departments: Clinical Nutrition Department, Food Services Department, Catering Services, Nursing Department and Physicians 1. Purpose: 1.1 To define the policy and establish applicable on procedure that will serve as guidelines for all staff involved in ordering meals (regular, therapeutic diets & nutritional supplements)

More information

DERBY-BURTON LOCAL CANCER NETWORK FILENAME R-CODOX-M.DOC CONTROLLED DOC NO: HCCPG B115 CSIS Regimen Name: R-CODOXM. Rituximab + CODOX-M

DERBY-BURTON LOCAL CANCER NETWORK FILENAME R-CODOX-M.DOC CONTROLLED DOC NO: HCCPG B115 CSIS Regimen Name: R-CODOXM. Rituximab + CODOX-M Rituximab + CODOX-M Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Indication Burkitt

More information

BNF CHAPTER 9: NUTRITION & BLOOD

BNF CHAPTER 9: NUTRITION & BLOOD 9.1 ANAEMIAS BNF CHAPTER 9: NUTRITION & BLOOD 9.1.1 IRON-DEFICIENCY ANAEMIAS 9.1.1.1 ORAL IRON Use of modified release iron preparations is not recommended since these preparations release iron beyond

More information

Unit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration

Unit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration Unit 11 Fluids, Electrolytes and Acid Base Imbalances Intravenous Access Devices & Common IV Fluids Objectives Review the purpose and types of intravenous (IV) therapy. Recall the nursing care related

More information

Vitamin and Mineral Supplementation and Monitoring. Bariatric Surgery

Vitamin and Mineral Supplementation and Monitoring. Bariatric Surgery Vitamin and Mineral Supplementation and Monitoring Bariatric Surgery We put our patients first by working as one team; leading and listening, and striving for the best. Together, we make the difference.

More information

PRODUCT INFORMATION RESONIUM A. Na m

PRODUCT INFORMATION RESONIUM A. Na m PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION

More information